Le Lézard
Classified in: Health, Business
Subject: PER

David Bailey joins Euclid Life Science Specialty, LLC


ITASCA, Ill., Dec. 1, 2020 /PRNewswire-PRWeb/ -- Euclid Life Science Specialty, LLC, an Itasca-based specialty program administrator for life science liability, is pleased to announce the hire of David N. Bailey as vice president of underwriting and executive underwriter. David's focus will be growing the company's presence and core book of life science products-work hazard liability and professional liability on the West Coast and partnering with executive leadership to expand product offerings for the Life Science industry.

David brings more than 20 years of experience in life science and technology related underwriting to the Euclid Life Science Specialty team. Prior to joining Euclid Life Science, Mr. Bailey served as the Commercial Director of Life Science for CNA and held medtech leadership, risk control and underwriting roles with Travelers/St Paul and Fireman's Fund.

Managing principal of Euclid Life Science, Ryann Elliott states "David's driven marketplace presence and rich underwriting expertise builds on our extensive academic focus and experience necessary to service client needs in this highly complex industry sector. His focus on growing the team and the book on the West Coast will aid in balancing our team."

Mr. Bailey holds a Bachelor of Science Business Administration from University of California at Riverside and is based in California, reporting to Elliott. He can be contacted directly by phone at +1.213. 247.2250, or via e-mail at [email protected]

About Euclid Life Science Specialty, LLC
Euclid Life Science Specialty, LLC is a specialty a product and professional liability insurance underwriting platform, providing tailored casualty coverage solutions to the life sciences industry and underwrite with capacity from a leading US insurer rated A+ by both A.M. Best and Standard & Poor's.

About Euclid Insurance Services, Inc.
Founded in 1952, Euclid Insurance Services, Inc. is a program administrator for specialty property/casualty insurance programs operating under the names Euclid Public Sector, Euclid Specialty Managers, Euclid Transactional, Euclid Enviant, Euclid Design Underwriters and Euclid Financial Institution Underwriters and functions as a general agency distributing employee benefit and life products under the name Euclid Managers.

For information on Euclid Life Science visit http://www.euclidlss.com and for information on the Euclid Insurance Services, Inc., visit http://www.euclidprograms.com.

Media Contact

Ryann Elliott, Euclid Life Science Specialty, LLC, +1 443-682-0102, [email protected]

 

SOURCE Euclid Life Science Specialty, LLC


These press releases may also interest you

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Amwins Global Risks is delighted to announce Classic Cars and Cotswolds, an auction to raise money for the Matthew Wilson Multiple Myeloma Fund at Blood Cancer UK. The online auction opens today and features Ferraris, Aston Martins, a Rolls Royce, a...

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...



News published on and distributed by: